|
|
|
Insider
Information: |
Khuong Chau Quang |
Relationship: |
Director, 10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
43,968 |
|
Indirect Shares
|
15,132,984 |
|
|
Direct
Value |
$1,196,458 |
|
|
Indirect Value
|
$15,247,785 |
|
|
Total
Shares |
15,176,952 |
|
|
Total
Value |
$16,444,243 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
11
|
Stock
price went up :
|
0
|
11
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
11.0
|
Percentage
Gain/Loss : |
-31.6%
|
1,065.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Otonomy, Inc. |
OTIC |
Director |
2014-08-18 |
0 |
2015-11-30 |
1,850,094 |
Premium* |
|
Pieris Pharmaceuticals, Inc. |
PIRS |
Director, 10% Owner |
|
0 |
2015-07-06 |
65,398 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
Director, 10% Owner |
|
0 |
2016-12-30 |
391,960 |
Premium* |
|
Aadi Bioscience, Inc |
AADI |
Director, 10% Owner |
2017-03-15 |
0 |
2018-06-28 |
5,193,946 |
Premium* |
|
Synlogic Inc |
SYBX |
Director |
|
0 |
2021-04-20 |
3,696,662 |
Premium* |
|
Inspire Medical Systems Inc |
INSP |
Director |
2020-10-09 |
1,875 |
2020-08-18 |
0 |
Premium* |
|
Nextcure, Inc. |
NXTC |
Director |
2019-05-13 |
0 |
2019-05-13 |
2,711,013 |
Premium* |
|
Fusion Pharmaceuticals Inc. |
FUSN |
Director |
2022-11-11 |
42,093 |
2020-06-30 |
192,100 |
Premium* |
|
Galecto Inc. |
GLTO |
Director, 10% Owner |
2020-11-02 |
0 |
2020-11-02 |
1,031,811 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PIRS |
Pieris Pharmaceuticals, I... |
Director |
|
2015-06-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,759,620 |
|
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
391,960 |
|
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2017-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,653,451 |
|
- |
|
SYBX |
Synlogic Inc |
Director |
|
2017-08-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,314,996 |
|
- |
|
OTIC |
Otonomy, Inc. |
Director |
|
2014-08-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,084,523 |
2,084,523 |
0 |
- |
|
INSP |
Inspire Medical Systems I... |
Director |
|
2018-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
2,131,721 |
2,131,721 |
0 |
- |
|
NXTC |
Nextcure, Inc. |
Director |
|
2019-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,361,013 |
2,361,013 |
0 |
- |
|
INSP |
Inspire Medical Systems I... |
Director |
|
2020-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
183 |
1,656 |
0 |
- |
|
FUSN |
Fusion Pharmaceuticals In... |
Director |
|
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,224,770 |
2,224,770 |
0 |
- |
|
INSP |
Inspire Medical Systems I... |
Director |
|
2020-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
128 |
1,784 |
0 |
- |
|
GLTO |
Galecto Inc. |
Director |
|
2020-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,069,922 |
191,787 |
0 |
- |
|
FUSN |
Fusion Pharmaceuticals In... |
Director |
|
2022-11-11 |
4 |
A |
$2.38 |
$100,181 |
D/D |
42,093 |
42,093 |
0 |
- |
|
PIRS |
Pieris Pharmaceuticals, I... |
Director |
|
2015-07-06 |
4 |
B |
$2.75 |
$1,375,000 |
I/I |
500,000 |
65,398 |
2.25 |
- |
|
SYBX |
Synlogic Inc |
Director |
|
2021-04-20 |
4 |
A |
$3.00 |
$4,999,998 |
I/I |
1,666,666 |
3,696,662 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-06-28 |
4 |
B |
$3.85 |
$2,993,375 |
I/I |
777,500 |
5,193,946 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2017-03-15 |
4 |
B |
$5.00 |
$3,814,975 |
I/I |
762,995 |
4,416,446 |
2.25 |
- |
|
SYBX |
Synlogic Inc |
Director |
|
2018-01-26 |
4 |
A |
$9.75 |
$6,971,250 |
I/I |
715,000 |
2,029,996 |
0 |
- |
|
NXTC |
Nextcure, Inc. |
Director |
|
2019-05-13 |
4 |
B |
$15.00 |
$5,250,000 |
I/I |
350,000 |
2,711,013 |
2.1 |
- |
|
GLTO |
Galecto Inc. |
Director |
|
2020-11-02 |
4 |
B |
$15.00 |
$10,999,995 |
I/I |
733,333 |
1,031,811 |
2.25 |
- |
|
OTIC |
Otonomy, Inc. |
Director |
|
2014-08-18 |
4 |
B |
$16.00 |
$2,750,000 |
I/I |
171,875 |
2,256,398 |
2.25 |
- |
|
INSP |
Inspire Medical Systems I... |
Director |
|
2018-05-07 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
2,444,221 |
2.25 |
- |
|
FUSN |
Fusion Pharmaceuticals In... |
Director |
|
2020-06-30 |
4 |
B |
$17.00 |
$15,266,000 |
I/I |
898,000 |
192,100 |
2.1 |
% |
|
OTIC |
Otonomy, Inc. |
Director |
|
2015-11-23 |
4 |
S |
$28.45 |
$2,298,760 |
I/I |
(80,800) |
1,953,300 |
0 |
- |
|
OTIC |
Otonomy, Inc. |
Director |
|
2015-11-20 |
4 |
S |
$28.59 |
$2,398,701 |
I/I |
(83,900) |
2,034,100 |
0 |
- |
|
OTIC |
Otonomy, Inc. |
Director |
|
2015-11-19 |
4 |
S |
$28.60 |
$3,640,780 |
I/I |
(127,300) |
2,118,000 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|